plusbacin A3: inhibits peptidoglycan synthesis in Staphylococcus aureus [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 168315246 |
| MeSH ID | M0396976 |
| Synonym |
|---|
| plusbacin a3 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cyanides | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor | 2018 | 2018 | 6.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| hexafluoroisopropanol | organofluorine compound; secondary alcohol | drug metabolite | 2018 | 2018 | 6.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| vancomycin | glycopeptide | antibacterial drug; antimicrobial agent; bacterial metabolite | 2001 | 2007 | 20.0 | medium | 0 | 0 | 0 | 2 | 0 | 0 | |
| acetylglucosamine | N-acetyl-D-glucosamine | epitope | 2001 | 2001 | 23.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| deuterium | dihydrogen | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | ||
| glycidyl nitrate | 2001 | 2017 | 13.7 | high | 0 | 0 | 0 | 1 | 2 | 0 | |||
| katanosin b | 2001 | 2001 | 23.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bacterial Disease | 0 | 2013 | 2013 | 11.0 | high | 0 | 0 | 0 | 0 | 1 | 0 | |
| Bacterial Infections | 0 | 2013 | 2013 | 11.0 | high | 0 | 0 | 0 | 0 | 1 | 0 | |
| Infections, Staphylococcal | 0 | 2013 | 2013 | 11.0 | high | 0 | 0 | 0 | 0 | 1 | 0 | |
| Staphylococcal Infections | 0 | 2013 | 2013 | 11.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |